DJIA 17,619.51 23.16 0.13%
NASDAQ 4,986.87 28.40 0.57%
S&P 500 2,063.11 5.47 0.27%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

57.55 1.50 (2.68%)

REAL-TIME: Last trade at

Extended Hours: $57.91 $0.39 (0.68%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

ISIS $57.55 2.68%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $57.39
Previous Close $56.05
Daily Range $55.62 - $57.86
52-Week Range $27.37 - $77.80
Market Cap $6.9B
P/E Ratio -280.25
Dividend (Yield) $0.00 (0.0%)
Volume 2,946,141
Average Daily Volume 2,509,207
Current FY EPS -$0.26




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Should Isis Pharmaceuticals (ISIS) Be On Your Radar Now? - Tale of the Tape

Isis Pharmaceuticals Inc. Investors Can Finally Sense a Bright Future

After decades of zero return, Isis Pharmaceuticals' stock has been on fire recently. Is it smart to jump on board now?

Commit To Purchase Isis Pharmaceuticals At $33, Earn 9.1% Using Options

Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog

ISIS Pharma Still Undervalued, Needham Says

IWM, CRBN: Big ETF Inflows

Health Care Sector Update for 06/22/2015: PFE, ISIS, KPTI

Amgen, Regeneron LDL-Lowering Drugs Provide Major Upside Potential To Their Stocks

Why I'm Shorting Biotech

Biotech has been crushing the broader markets for several years running at this point. However, this amazing run might be about to come to a screeching halt, making now a good time to short biotech.

See More ISIS News...

ISIS's Top Competitors

ISIS $57.55 (2.68%)
Current stock: ISIS
AMGN $153.52 (1.27%)
Current stock: AMGN
GILD $117.08 (1.41%)
Current stock: GILD
BIIB $403.94 (1.95%)
Current stock: BIIB